Cero Therapeutics Holdings, Inc.
CERO- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCEROW
Q2 2024 vs. Q1 2024
How the institutions holding Cero Therapeutics Holdings, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 9 | 15 | +6 |
| Shares | 1.67M | 1.94M | +278.5K (+16.7%) |
| Value | $4.85M | $557.1K | −$4.30M (−88.5%) |
New holders (8)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Arena Investors LP | 198,566 | $59.4K | 1.01% |
| Avantax Planning Partners, Inc. | 80,000 | $23.9K | 0.00% |
| Two Sigma Investments, LP | 18,096 | $5.41K | 0.00% |
| CI Private Wealth, LLC | 14,999 | $4.49K | 0.00% |
| HRT Financial LP | 11,935 | $3.00K | 0.00% |
| Advisor Group Holdings, Inc. | 400 | $120 | 0.00% |
| Bank of America Corp | 68 | $20 | 0.00% |
| Fifth Lane Capital, LP | 76,593 | $0 | 0.00% |
Sold out (2)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| SC China Holding Ltd | 149,999 | $202.5K |
| Kestra Private Wealth Services, LLC | 10,000 | $30.7K |